Table of Contents

• J A Colwell

Elevated plasma homocysteine and diabetic vascular disease.

• H Storm,
• C Thomsen,
• E Pedersen,
• O Rasmussen,
• C Christiansen,
• and K Hermansen

Comparison of a carbohydrate-rich diet and diets rich in stearic or palmitic acid in NIDDM patients. Effects on lipids, glycemic control, and diurnal blood pressure.

• A M Nugent,
• I C Steele,
• F al-Modaris,
• S Vallely,
• A Moore,
• N P Campbell,
• P M Bell,
• K D Buchanan,
• E R Trimble,
• and D P Nicholls

Exercise responses in patients with IDDM.

• A Avignon,
• A Radauceanu,
• and L Monnier

Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

• F Holleman,
• H Schmitt,
• R Rottiers,
• A Rees,
• S Symanowski,
• and J H Anderson

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group.

• T Rönnemaa,
• H Hämäläinen,
• T Toikka,
• and I Liukkonen

Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects.

• F Otsuka,
• T Ogura,
• T Yamauchi,
• K Shikata,
• J Kageyama,
• and H Makino

IDDM accompanied by a growth hormone-producing pituitary adenoma. A case report.

• C S Shin,
• H K Lee,
• C S Koh,
• Y I Kim,
• Y S Shin,
• K Y Yoo,
• H Y Paik,
• Y S Park,
• and B G Yang

Risk factors for the development of NIDDM in Yonchon County, Korea.

• T P Gilmer,
• P J O'Connor,
• W G Manning,
• and W A Rush

The cost to health plans of poor glycemic control.

• P J Anderson,
• J C Chan,
• Y L Chan,
• B Tomlinson,
• R P Young,
• Z S Lee,
• K K Lee,
• C Metreweli,
• C S Cockram,
• and J A Critchley

Visceral fat and cardiovascular risk factors in Chinese NIDDM patients.

• M I Harris,
• R C Eastman,
• C C Cowie,
• K M Flegal,
• and M S Eberhardt

Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria.

• F Abbasi,
• V Kamath,
• A A Rizvi,
• M Carantoni,
• Y D Chen,
• and G M Reaven

Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.

• M M Janssen,
• S Casteleijn,
• W Devillé,
• C Popp-Snijders,
• P Roach,
• and R J Heine

Nighttime insulin kinetics and glycemic control in type 1 diabetes patients following administration of an intermediate-acting lispro preparation.

• M K Gutniak,
• H Larsson,
• S W Sanders,
• O Juneskans,
• J J Holst,
• and B Ahrén

GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions.

• M A Hofmann,
• B Kohl,
• M S Zumbach,
• V Borcea,
• A Bierhaus,
• M Henkels,
• J Amiral,
• W Fiehn,
• R Ziegler,
• P Wahl,
• and P P Nawroth

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

• N Sakane,
• T Yoshida,
• T Umekawa,
• A Kogure,
• Y Takakura,
• and M Kondo

Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients.

• G Tonolo,
• M Ciccarese,
• P Brizzi,
• L Puddu,
• G Secchi,
• P Calvia,
• M M Atzeni,
• M G Melis,
• and M Maioli

Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment.

• H Shigeta,
• M Yamaguchi,
• K Nakano,
• H Obayashi,
• R Takemura,
• M Fukui,
• M Fujii,
• K Yoshimori,
• G Hasegawa,
• N Nakamura,
• Y Kitagawa,
• and M Kondo

Serum autoantibodies against sulfatide and phospholipid in NIDDM patients with diabetic neuropathy.

• R D Hoeldtke,
• K D Bryner,
• G G Horvath,
• M R Byerly,
• G R Hobbs,
• S M Marcovina,
• and A Lernmark

Antibodies to GAD and glycemic control in recent-onset IDDM.

• E C Katoulis,
• M Ebdon-Parry,
• H Lanshammar,
• L Vileikyte,
• J Kulkarni,
• and A J Boulton

Gait abnormalities in diabetic neuropathy.

Diabetes mellitus and exercise. American Diabetes Association.

• Z T Bloomgarden

American Diabetes Association Annual Meeting, 1997. Obesity, diabetes prevention, and type 1 diabetes.

• J Köbberling and
• M Hompesch

alpha-Lipoic acid in NIDDM patients with cardiac autonomic neuropathy.

• R Kimmerle and
• W Klockenbusch

Plasma endothelin in normal and diabetic pregnancy.

• F Relimpio,
• D Acosta,
• F Losada,
• A Pumar,
• J L Serrera,
• M A Mangas,
• and R Astorga

High lipoprotein(a) levels in type 1 and type 2 diabetic patients with macroalbuminuria.

• S Jain,
• C B Kahn,
• J Pella,
• and J R Myers

Noncardiogenic pulmonary edema in a patient with diabetic ketoacidosis.

• G Winkler,
• F Salamon,
• M Porochnavec,
• D Solymosi,
• J Demeter,
• K Simon,
• D Salamon,
• I Karádi,
• K Cseh,
• and L Romics

Intimal-medical thickness of the carotid artery in NIDDM patients.

• A Tashiro,
• M Hongo,
• R Ota,
• A Utsumi,
• and T Imai

Hyper-insulin response in a patient with depression. Changes in insulin resistance during recovery from depression.

• M A Omar and
• A A Motala

Fasting in Ramadan and the diabetic patient.

• C Szalai,
• A Császár,
• A Czinner,
• M Bihari-Varga,
• and L Romics

Apolipoprotein A-IV and E polymorphisms in children with IDDM.